News

Gladstone in the News February 14, 2023

S.F.’s Gladstone Institutes Plans Major Expansion, a Potential Boon for the City’s Slow Recovery

San Francisco Chronicle—Gladstone President Deepak Srivastava and San Francisco Mayor London Breed say Gladstone's planned 75,000 square feet extension will sizably increase the institute's impact on unsolved diseases and contribute to the city's economic recovery.

Office of the President Institutional News

Gladstone in the News February 14, 2023

Gladstone Institutes Plans $160M Expansion in Mission Bay

San Francisco Business Times—Gladstone Institutes announced a plan to expand on its current building in the Mission Bay neighborhood of San Francisco, with construction beginning in 2024. The expansion will provide space for over 12 new labs.

Institutional News

Article February 14, 2023

Gladstone Institutes to Expand Its Footprint

Building expansion will provide space for over a dozen new labs

Institutional News News Release

Gladstone in the News February 10, 2023

Filming a Movie Using CRISPR Technology

Science is Fun Podcast—Assistant Investigator Seth Shipman describes his remarkable technological advance repurposing CRISPR gene editing technology to record information inside living cells.

Gladstone Experts Data Science and Biotechnology Shipman Lab CRISPR/Gene Editing

Photo Album February 10, 2023

Highlighting Black Scientists from Past to Present

Featuring Black scientists throughout history

Elevated Voices Diversity

Article February 2, 2023

“The Most Amazing Thing I’ve Ever Seen:” Heart Development Comes Alive

A Q&A with Gladstone Investigator Benoit Bruneau

Research (Publication) Congenital Heart Disease Cardiovascular Disease Bruneau Lab

Article January 27, 2023

“It Was a Life-Changing Experience”: What Past Interns Are Saying about the PUMAS Program

Past PUMAS interns share how the program has impacted their scientific journeys

Student Outreach and Science Education

Gladstone in the News January 26, 2023

The Race to Supercharge Cancer-Fighting T Cells

Nature—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, and his colleagues have been using CRISPR to increase the therapeutic potential of T cells. This work is part of a worldwide effort to improve the design and manufacturing of cancer-killing ‟CAR-T” cells reviewed in the journal Nature.

Gladstone Experts Cancer Genomic Immunology Marson Lab CRISPR/Gene Editing

Article January 18, 2023

Meet Gladstone: Aditya Naik

As his interest in lab management began to grow, Aditya Naik jumped on the opportunity to join the newly formed Pelka lab at Gladstone

Research Associates Committee Profile Pelka Lab

Article January 13, 2023

Evolution of Uniquely Human DNA Was a Balancing Act, Study Concludes

Many changes to the genomes of early humans had opposing effects from each other, possibly because of a delicate balance between improved cognition and psychiatric disease risk

News Release Research (Publication) Data Science and Biotechnology Pollard Lab

Gladstone in the News December 23, 2022

Parker Institute Extends ‘Crazy Idea’ Funding to Two More Cancer Centers

STAT News—The Parker Institute for Cancer Immunotherapy has expanded to include a new center at Gladstone Institutes. Center Director Alex Marson says the funding will enable Gladstone scientists to take on bold, high-risk ideas and create better cell therapies for cancer.

Institutional News Cancer Genomic Immunology Marson Lab

Article December 20, 2022

Biomedical Research That “Flows” in New Directions

Improvements in the cell analysis technique known as flow cytometry are helping Gladstone researchers make discoveries in immunology, stem cell biology, cardiology, and neuroscience

Gladstone Experts Flow Cytometry Core Neurological Disease Alexanian Lab Roan Lab

Article December 19, 2022

2022 Year in Review

See what we've been up to in 2022

Communications History

Article December 16, 2022

Tips from Virologists to Face the “Tripledemic” This Holiday Season

Gladstone scientists answer questions about the convergence of COVID-19, RSV, and the flu this winter

Gladstone Experts COVID-19 Infectious Disease Greene Lab Ott Lab Roan Lab

Gladstone in the News December 10, 2022

New COVID Subvariants Are ‘the Most Immune Evasive Yet.’ Here’s What That Means

San Francisco Chronicle—New SARS-CoV-2 subvariants are driving an increase in COVID case numbers around the world. Gladstone Investigator Nadia Roan explains that the subvariants have mutations that help them evade neutralizing antibodies, but stresses that getting the bivalent vaccine can still help strengthen immunity to the ever-changing virus.

Gladstone Experts COVID-19 Infectious Disease Roan Lab